This blog will cover topics concerning the implementation of clinical genomics to the point it becomes standard of care. These blog posts are not AI-generated but are based on real-world experience and an unrestricted point of view. All content will combine industry information with my perspectives on all components of the clinical genomics ecosystem.
Many of the blog posts will include accompanying content such as exclusive perspective reports, one-page factsheets, call-to-action projects and updates, surveys and their results, and more. Below are descriptions of the major content items in Moving Forward.
This report provides more in-depth coverage of the information presented in the blog article. It delves deeper into the key points and offers additional insights and analysis. It provides a broader context for the topic being discussed. The report also includes more comprehensive and nuanced conclusions, as well as potential implications for further ideas, making it a valuable resource for readers who want to gain a deeper understanding of the issues and opportunities to move forward.
These summaries contain bulleted items of the major points of the issue. They also contain the next steps for solution implementation and an outlook on industry adoption. The Executive Highlights column contains additional insights that decision-making and funding leaders should consider.
Participating in surveys on the business of clinical genomics can provide valuable insights into the current state and future direction of the field. After identifying the challenges and opportunities we are collectively facing, we plan to promote solutions that will shape the industry. By taking a few short minutes, you can contribute your perspectives and experiences, which can identify trends and challenges, and inform new policies and business decisions.
Joining a call-to-action from any of the ideas presented in the blog articles will help to increase your engagement with the industry and keep you up-to-date on the latest trends and developments. By participating in calls-to-action, you can connect with other professionals in your field and gain valuable insights into the challenges and opportunities that we face in this industry. Moving Forward’s Calls-to-Action, which include sharing ideas, efforts, and results, offers a unique way to stay connected, informed, and engaged in driving the future of clinical genomics.